Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Who owns ONCTERNAL THERAPEUTICS INC COM?

Ticker: ONCT
CUSIP Number: 68236p206

Tip: Access positions for across all investors

Analyze quarterly positions in Oncternal Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csv

Download as Excel

Top investors of Oncternal Therapeutics stock

Who bought or sold ONCTERNAL THERAPEUTICS INC COM this quarter?

Fund or Company Name	Shares Held	Valued At	Change in Shares	As Of	Actions
Vanguard Group	143k	$1.3M	100%	Mar 2024	View chart
Millennium Management	103k	$928k	100%	Mar 2024	View chart
BlackRock	39k	$354k	100%	Mar 2024	View chart
Quantum Private Wealth	28k	$250k	100%	Mar 2024	View chart
Dimensional Fund Advisors	26k	$233k	100%	Mar 2024	View chart
Richmond Brothers	25k	$222k	100%	Mar 2024	View chart
Geode Capital Management	24k	$217k	100%	Mar 2024	View chart
Brighton Jones	17k	$152k	100%	Mar 2024	View chart
Morgan Stanley	11k	$97k	100%	Mar 2024	View chart
Susquehanna International	10k	$92k	100%	Mar 2024	View chart
ADAR1 Capital Management	2.5k	$22k	100%	Mar 2024	View chart
Acadian Asset Management	1.9k	$17k	100%	Mar 2024	View chart
Jpmorgan Chase & Co	1.0k	$9.0k	100%	Mar 2024	View chart
Tower Research Capital	664.00	$6.0k	100%	Mar 2024	View chart
Wells Fargo & Company	322.00	$2.9k	100%	Mar 2024	View chart
Advisor Group Holdings	287.00	$2.6k	100%	Mar 2024	View chart
North Star Investment Management	250.00	$2.3k	-95%	Mar 2024	View chart
Bnp Paribas Arbitrage, Snc	182.00	$1.6k	100%	Mar 2024	View chart
UBS Group	100.00	$900.000000	100%	Mar 2024	View chart
Steward Partners Investment Advisory	15.00	$135.000000	100%	Mar 2024	View chart
Lindbrook Capital	15.00	$135.000000	-95%	Mar 2024	View chart
Nemes Rush Group	3.00	$27.000000	100%	Mar 2024	View chart

Who sold out of Oncternal Therapeutics?

Fund or Company Name	Date Sold	Shares Held	Valued At
Aureus Asset Management	Dec 2023	30k	$16k
Valeo Financial Advisors	Dec 2023	24k	$13k

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z